In patients with T2D who had been hospitalized for poorly controlled blood glucose, SGLT2 inhibitors nearly doubled the risk ...

Nearly a quarter of patients with difficult-to-control type 2 diabetes have hypercortisolism, with even higher prevalence ...

Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...

A new study has found increased risks for liver, pancreatic, and bowel cancers following a new diagnosis of type 2 ...

In 2021, roughly 6% of the world's population, or 529 million people, were living with diabetes, mostly type 2 diabetes (T2D) ...

Both GLP-1 RAs and SGLT2is are associated with a reduced risk for Alzheimer disease and related dementias among people with T2D.

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

Diuretic use does not affect safety and efficacy outcomes in patients with type 2 diabetes and chronic kidney disease receiving finerenone.

In a study of adults with diabetes and gastrointestinal (GI) motility abnormalities, over 75% had GI motility abnormalities.

Shares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the primary goal of significantly reducing A1C levels compared to placebo at ...

This type of diabetes shares characteristics of both type 1 (T1D) and type 2 (T2D) diabetes. As an autoimmune condition that develops during adulthood, LADA is not tied to lifestyle habits or ...